“…Female BALB/c mice were similarly immunized with recombinant LF (rLF; List Biological Laboratories, Campbell, CA), and spleens were harvested and used to make hybridomas. Immune spleen cells were fused with mouse myeloma cells using standard procedures routinely used in our laboratory (14,31,35,44,45,52,55). Hybridomas producing anti-rPA or anti-rLF antibodies were screened by enzyme-linked immunosorbent assay (ELISA) using rPA or rLF as the coating antigen, respectively.…”